The Varying Benefits of Two Years Automated Insulin Delivery System Use on Continuous Glucose Monitoring Profiles in Children and Adolescents with Type 1 Diabetes

Background: Automated insulin delivery (AID) systems are recommended for youths with type 1 diabetes, but real-world longitudinal data remains limited despite increasing use. This study evaluates the effect of 2 years of AID use on continuous glucose monitoring (CGM) profiles and body mass index (BMI) development. Methods: Data from individuals with type 1 diabetes aged <18 years, diabetes duration >3 months, and AID use of >3 months from the Diabetes Prospective Follow-up (DPV) Registry between 2019 and 2025 were analyzed. CGM and HbA1c were required at the last documented time in range (TIR) (±90 days; follow-up) and 2 years earlier (±90 days; baseline). Changes were investigated using adjusted regression models with repeated measurements. Findings: Data from 2486 participants (baseline: median age: 11.9 years, diabetes duration: 5.0 years, 53% male) were analyzed over ∼23 months. The largest gains occurred in time in tight range (TiTR) (42.4% [95% confidence interval: 41.0–43.7] to 50.1% [48.8–51.4]; P < 0.001) and coefficient of variation (CV) (32.9 [32.0–33.7] to 29.5 [28.7–30.2]; P < 0.001). HbA1c (7.3% [7.2–7.3] to 7.2 [7.1–7.2]; P < 0.001), TIR (64.5% [63.9–65.1] to 66.7% [66.1–67.3]; P < 0.001), and mean sensor glucose (SG) (161.0 mg/dL [158.4–163.5] to 155.5 mg/dL [153.1–157.9]; P = 0.001) improved statistically, but below clinical relevance thresholds. Time below range (TBR) < 70 mg/dL increased (2.7% [2.6–2.9] to 3.2% [3.1–3.4]; P < 0.001), TBR < 54 mg/dL remained stable (1.7%–1.8%; P = 0.516), and severe hypoglycemia decreased (6.4–4.5/100 patient-years; P < 0.001). No changes were seen in children <6 years. In youth 6 to <12 and 12 to <18 years, TiTR and CV improved most, while TBR increased. BMI-standard deviation score (SDS) increased (0.57 [0.53–0.61] to 0.67 [0.63–0.72]; P < 0.001). Conclusion: After 2 years of AID use, TiTR and CV showed clinically relevant improvements, while TBR < 70 mg/dL increased with stable TBR < 54 mg/dL and severe hypoglycemia decreased. Changes in TIR, SG, and HbA1c were statistically significant but small, yet noteworthy, as glycemia usually deteriorates during adolescence. The increase in BMI-SDS needs to be further investigated.

Authors

Institutions

Publication Details

Journal
Diabetes Technology & Therapeutics
Published
2026-11-21
DOI
https://doi.org/10.1177/15209156261507763
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Varying Benefits of Two Years Automated Insulin Delivery System Use on Continuous Glucose Monitoring Profiles in Children and Adolescents with Type 1 Diabetes

Jantje Weiskorn, Marie‐Anne Burckhardt, Nicole Blauensteiner, Marie Auzanneau et al.
Diabetes Technology & Therapeutics
Diabetes Management and Research
article

The Varying Benefits of Two Years Automated Insulin Delivery System Use on Continuous Glucose Monitoring Profiles in Children and Adolescents with Type 1 Diabetes

Jantje Weiskorn, Marie‐Anne Burckhardt, Nicole Blauensteiner, Marie Auzanneau, Stefanie Lanzinger, Ulrike Helga Elisabeth Schierloh, Julia Schneidewind, Isa Mayer
article en

Abstract

Background: Automated insulin delivery (AID) systems are recommended for youths with type 1 diabetes, but real-world longitudinal data remains limited despite increasing use. This study evaluates the effect of 2 years of AID use on continuous glucose monitoring (CGM) profiles and body mass index (BMI) development. Methods: Data from individuals with type 1 diabetes aged <18 years, diabetes duration >3 months, and AID use of >3 months from the Diabetes Prospective Follow-up (DPV) Registry between 2019 and 2025 were analyzed. CGM and HbA1c were required at the last documented time in range (TIR) (±90 days; follow-up) and 2 years earlier (±90 days; baseline). Changes were investigated using adjusted regression models with repeated measurements. Findings: Data from 2486 participants (baseline: median age: 11.9 years, diabetes duration: 5.0 years, 53% male) were analyzed over ∼23 months. The largest gains occurred in time in tight range (TiTR) (42.4% [95% confidence interval: 41.0–43.7] to 50.1% [48.8–51.4]; P < 0.001) and coefficient of variation (CV) (32.9 [32.0–33.7] to 29.5 [28.7–30.2]; P < 0.001). HbA1c (7.3% [7.2–7.3] to 7.2 [7.1–7.2]; P < 0.001), TIR (64.5% [63.9–65.1] to 66.7% [66.1–67.3]; P < 0.001), and mean sensor glucose (SG) (161.0 mg/dL [158.4–163.5] to 155.5 mg/dL [153.1–157.9]; P = 0.001) improved statistically, but below clinical relevance thresholds. Time below range (TBR) < 70 mg/dL increased (2.7% [2.6–2.9] to 3.2% [3.1–3.4]; P < 0.001), TBR < 54 mg/dL remained stable (1.7%–1.8%; P = 0.516), and severe hypoglycemia decreased (6.4–4.5/100 patient-years; P < 0.001). No changes were seen in children <6 years. In youth 6 to <12 and 12 to <18 years, TiTR and CV improved most, while TBR increased. BMI-standard deviation score (SDS) increased (0.57 [0.53–0.61] to 0.67 [0.63–0.72]; P < 0.001). Conclusion: After 2 years of AID use, TiTR and CV showed clinically relevant improvements, while TBR < 70 mg/dL increased with stable TBR < 54 mg/dL and severe hypoglycemia decreased. Changes in TIR, SG, and HbA1c were statistically significant but small, yet noteworthy, as glycemia usually deteriorates during adolescence. The increase in BMI-SDS needs to be further investigated.

Diabetes Technology & Therapeutics
Centre Hospitalier de Luxembourg (LU), University of Basel (CH), Universität Ulm (DE), University Hospital Bonn (DE), Kinderkrankenhaus auf der Bult (DE), Comprehensive Cancer Center Vienna (AT), University Children’s Hospital Basel (CH), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), Heinrich Heine University Düsseldorf (DE), Medical University of Vienna (AT), University of Lübeck (DE)
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon